These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 8438442

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Indications for mycofenolate mofetil therapy after liver transplantation.
    Platz KP, Mueller AR, Neuhaus P.
    Transplant Proc; 1997 Nov; 29(7):2880-1. PubMed ID: 9365601
    [No Abstract] [Full Text] [Related]

  • 4. FK 506 and mycofenolate mofetil rescue for acute steroid-resistant and chronic rejection after liver transplantation.
    Platz KP, Mueller AR, Neuhaus R, Keck HH, Lobeck H, Neuhaus P.
    Transplant Proc; 1997 Nov; 29(7):2872-4. PubMed ID: 9365598
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Reversal of chronic rejection after treatment failure with FK506 and RS61443.
    Roberts JP, Lake JR, Hebert M, Nikolai B, Ascher NL, Ferrell LD.
    Transplantation; 1993 Oct; 56(4):1021-3. PubMed ID: 7692634
    [No Abstract] [Full Text] [Related]

  • 7. Incidence and outcome of OKT3 treatment for early steroid-resistant rejection following hepatic transplantation.
    Lange D, Bechstein WO, Blumhardt G, Lemmens P, Schattenfroh N, Neuhaus P.
    Transplant Proc; 1993 Apr; 25(2):1870-1. PubMed ID: 8470207
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Chronic rejection in pediatric liver transplantation.
    Cho JH, Bhatnagar V, Andreani P, Muiesan P, Portmann B, Baker A, Mieli-Vergani G, Gibbs P, Rela M, Heaton ND.
    Transplant Proc; 1997 Apr; 29(1-2):452-3. PubMed ID: 9123078
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Late onset acute rejection of renal allografts, an indicator of suboptimum cyclosporin dosage.
    Sumethkul V, Jirasiritham S, Chiewsilp P.
    Transplant Proc; 1996 Jun; 28(3):1461-2. PubMed ID: 8658741
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Indication for mycophenolate mofetil therapy in hepatitis C patients undergoing liver transplantation.
    Platz KP, Mueller AR, Willimski C, Mansoorian B, Berg T, Neuhaus R, Hopf U, Radke C, Neuhaus P.
    Transplant Proc; 1998 Aug; 30(5):2232-3. PubMed ID: 9723453
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MYSS: should we alter clinical practice?
    Maes B, Vanrenterghem Y.
    Lancet; 1998 Aug; 364(9450):2016-7; author reply 2017-8. PubMed ID: 15582052
    [No Abstract] [Full Text] [Related]

  • 18. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
    Reissi D, Bardideh A, Samadzadeh B, Razi A.
    Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Significance of mycophenolate mofetil treatment in patients with HCV reinfection after liver transplantation: impact on clinical course and histologic damage.
    Bahra M, Neumann UP, Harren M, Jacob D, Langrehr JM, Berg T, Neuhaus R, Neuhaus P.
    Transplant Proc; 2002 Nov; 34(7):2934-5. PubMed ID: 12431663
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.